Completed PHASE4 INTERVENTIONAL 1-arm NCT01004653

A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines

An Open-Label Clinical Trial With Split-virion Influenza A/H1N1 Vaccines in Healthy Elders

Sponsor: Sinovac Biotech Co., Ltd

Conditions Influenza

Interventions H1N1 influenza A Vaccine (Split virion), Inactivated

Updated 5 times since 2017 Last updated: Mar 13, 2013 Started: Sep 30, 2009 Primary completion: Oct 31, 2009 Completion: Nov 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Influenza, this trial is completed. The trial is conducted by Sinovac Biotech Co., Ltd and has accumulated 5 data snapshots since 2009. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sinovac Biotech Co., Ltd

Data source: Sinovac Biotech Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China